Efficacy of combination azacitidine and lenalidomide
| Characteristic . | n (% or range) . |
|---|---|
| Overall response rate | 26/36 (72) |
| CR | 16 (44) |
| HI | 10 (28) |
| HI, erythroid | 3 (30) |
| HI, platelet | 3 (30) |
| HI, neutrophil | 4 (40) |
| Median time to initial response, mo | 3.7 (1.4-7.4) |
| Median CR duration, mo | 17+ (3-39+) |
| Median overall survival, mo, n = 36 | 13.6 (3-55) |
| Median overall survival among CR patients, mo, n = 16 | 37+ (7-55+) |
| Characteristic . | n (% or range) . |
|---|---|
| Overall response rate | 26/36 (72) |
| CR | 16 (44) |
| HI | 10 (28) |
| HI, erythroid | 3 (30) |
| HI, platelet | 3 (30) |
| HI, neutrophil | 4 (40) |
| Median time to initial response, mo | 3.7 (1.4-7.4) |
| Median CR duration, mo | 17+ (3-39+) |
| Median overall survival, mo, n = 36 | 13.6 (3-55) |
| Median overall survival among CR patients, mo, n = 16 | 37+ (7-55+) |
CR indicates complete response; and HI, hematologic improvement.